These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16288004)

  • 1. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.
    Chu F; Chou PM; Zheng X; Mirkin BL; Rebbaa A
    Cancer Res; 2005 Nov; 65(22):10183-7. PubMed ID: 16288004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of the SIRT1 protein deacetylase in cancer.
    Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
    Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
    Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance and malignancy in human osteosarcoma.
    Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
    Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.
    Ford J; Jiang M; Milner J
    Cancer Res; 2005 Nov; 65(22):10457-63. PubMed ID: 16288037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.
    Yagüe E; Higgins CF; Raguz S
    Gene Ther; 2004 Jul; 11(14):1170-4. PubMed ID: 15164094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt1 modulates premature senescence-like phenotype in human endothelial cells.
    Ota H; Akishita M; Eto M; Iijima K; Kaneki M; Ouchi Y
    J Mol Cell Cardiol; 2007 Nov; 43(5):571-9. PubMed ID: 17916362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1: tumor promoter or tumor suppressor?
    Lim CS
    Med Hypotheses; 2006; 67(2):341-4. PubMed ID: 16546327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1.
    Kaszubiak A; Kupstat A; Müller U; Hausmann R; Holm PS; Lage H
    Biochem Biophys Res Commun; 2007 May; 357(1):295-301. PubMed ID: 17418094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator.
    Xu D; Ye D; Fisher M; Juliano RL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):963-71. PubMed ID: 12183653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells.
    Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S
    Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
    Liu Y; Liu H; Han B; Zhang JT
    Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.